NASDAQ:BLFS - Biolife Solutions Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$9.04 -0.13 (-1.42 %)
(As of 05/23/2018 04:00 PM ET)
Previous Close$9.29
Today's Range$8.58 - $9.29
52-Week Range$2.13 - $9.25
Volume8,304 shs
Average Volume104,328 shs
Market Capitalization$126.18 million
P/E Ratio-41.14
Dividend YieldN/A
Beta0.31

About Biolife Solutions (NASDAQ:BLFS)

Biolife Solutions logoBioLife Solutions, Inc. develops, manufactures, and markets patented tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, and delayed-onset cell damage and death. The company offers HypoThermosol FRS, a hypothermic storage and shipping media product to mitigate temperature-induced molecular cell stress responses that occur during chilling and re-warming of biologics, intermediate products, and final cell products intended for research and clinical applications; and CryoStor cryopreservation freeze media products to mitigate temperature-induced molecular cell stress responses during freezing and thawing. It also provides BloodStor freeze media products, such as BloodStor 55-5 and BloodStor 100 for cryopreservation of stem and other cells isolated from umbilical cord and peripheral blood, and bone marrow; and cell thawing media, which offers Dextran and saline for washing cryopreserved cells and tissues to dilute or remove cryoprotectants. In addition, the company provides custom product formulation and packaging services; and contract aseptic manufacturing formulation, filling, and finishing services for liquid media products. It markets its products to the regenerative medicine, bio-banking, and drug discovery markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, and hair transplant centers, as well as suppliers of cells to the drug discovery, toxicology testing, and diagnostic markets. The company markets and sells its products directly using its sales force, as well as through biolifesolutions.com; and through various regional distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.

Receive BLFS News and Ratings via Email

Sign-up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:BLFS
CUSIPN/A
Phone425-402-1400

Debt

Debt-to-Equity RatioN/A
Current Ratio7.82
Quick Ratio6.42

Price-To-Earnings

Trailing P/E Ratio-41.14
Forward P/E Ratio-226.00
P/E GrowthN/A

Sales & Book Value

Annual Sales$11.02 million
Price / Sales11.61
Cash FlowN/A
Price / CashN/A
Book Value$0.74 per share
Price / Book12.22

Profitability

EPS (Most Recent Fiscal Year)($0.21)
Net Income$-2,510,000.00
Net Margins-13.17%
Return on Equity-18.99%
Return on Assets-15.72%

Miscellaneous

Employees40
Outstanding Shares14,150,000

Biolife Solutions (NASDAQ:BLFS) Frequently Asked Questions

What is Biolife Solutions' stock symbol?

Biolife Solutions trades on the NASDAQ under the ticker symbol "BLFS."

How were Biolife Solutions' earnings last quarter?

Biolife Solutions (NASDAQ:BLFS) released its quarterly earnings data on Thursday, March, 8th. The medical equipment provider reported ($0.05) EPS for the quarter, missing the Zacks' consensus estimate of ($0.04) by $0.02. The medical equipment provider had revenue of $3.13 million for the quarter, compared to the consensus estimate of $3.10 million. Biolife Solutions had a negative return on equity of 18.99% and a negative net margin of 13.17%. View Biolife Solutions' Earnings History.

When is Biolife Solutions' next earnings date?

Biolife Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for Biolife Solutions.

What price target have analysts set for BLFS?

3 brokerages have issued 1 year price objectives for Biolife Solutions' shares. Their forecasts range from $5.00 to $12.00. On average, they expect Biolife Solutions' share price to reach $8.50 in the next twelve months. View Analyst Ratings for Biolife Solutions.

Who are some of Biolife Solutions' key competitors?

Who are Biolife Solutions' key executives?

Biolife Solutions' management team includes the folowing people:
  • Mr. Michael P. Rice, Pres, CEO & Director (Age 55)
  • Mr. Roderick de Greef, CFO & Sec. (Age 58)
  • Dr. Aby J. Mathew, Chairman of Scientific Advisory Board, Chief Technology Officer and Sr. VP (Age 46)
  • Ms. Karen Foster, VP of Operations (Age 58)
  • Mr. Kevin O'Donnell, VP of Cold Chain Standards, Practices & Compliance

Has Biolife Solutions been receiving favorable news coverage?

Headlines about BLFS stock have trended somewhat positive recently, according to Accern. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Biolife Solutions earned a media sentiment score of 0.05 on Accern's scale. They also assigned news coverage about the medical equipment provider an impact score of 48.10 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Who are Biolife Solutions' major shareholders?

Biolife Solutions' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include GIRSCHWEILER THOMAS (21.60%), CASDIN CAPITAL, LLC (7.10%), Millennium Management LLC (1.71%) and Granite Investment Partners LLC (0.79%). Company insiders that own Biolife Solutions stock include Michael Rice and Thomas Girschweiler. View Institutional Ownership Trends for Biolife Solutions.

Which institutional investors are selling Biolife Solutions stock?

BLFS stock was sold by a variety of institutional investors in the last quarter, including Granite Investment Partners LLC. Company insiders that have sold Biolife Solutions company stock in the last year include Michael Rice and Thomas Girschweiler. View Insider Buying and Selling for Biolife Solutions.

Which institutional investors are buying Biolife Solutions stock?

BLFS stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC. View Insider Buying and Selling for Biolife Solutions.

How do I buy shares of Biolife Solutions?

Shares of BLFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Biolife Solutions' stock price today?

One share of BLFS stock can currently be purchased for approximately $9.04.

How big of a company is Biolife Solutions?

Biolife Solutions has a market capitalization of $126.18 million and generates $11.02 million in revenue each year. The medical equipment provider earns $-2,510,000.00 in net income (profit) each year or ($0.21) on an earnings per share basis. Biolife Solutions employs 40 workers across the globe.

How can I contact Biolife Solutions?

Biolife Solutions' mailing address is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. The medical equipment provider can be reached via phone at 425-402-1400 or via email at [email protected]


MarketBeat Community Rating for Biolife Solutions (BLFS)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  117 (Vote Outperform)
Underperform Votes:  64 (Vote Underperform)
Total Votes:  181
MarketBeat's community ratings are surveys of what our community members think about Biolife Solutions and other stocks. Vote "Outperform" if you believe BLFS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BLFS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Biolife Solutions (NASDAQ:BLFS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Biolife Solutions in the last 12 months. Their average twelve-month price target is $8.50, suggesting that the stock has a possible downside of 5.97%. The high price target for BLFS is $12.00 and the low price target for BLFS is $5.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $8.50$7.00$6.50$6.50
Price Target Upside: 5.97% downside17.06% upside11.11% upside26.21% upside

Biolife Solutions (NASDAQ:BLFS) Consensus Price Target History

Price Target History for Biolife Solutions (NASDAQ:BLFS)

Biolife Solutions (NASDAQ:BLFS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/11/2018Maxim GroupBoost Price TargetBuy ➝ Buy$9.00 ➝ $12.00HighView Rating Details
3/12/2018Northland SecuritiesInitiated CoverageOutperformHighView Rating Details
7/5/2017Janney Montgomery ScottUpgradeNeutral ➝ Buy$2.62 ➝ $5.00HighView Rating Details
(Data available from 5/23/2016 forward)

Earnings

Biolife Solutions (NASDAQ:BLFS) Earnings History and Estimates Chart

Earnings by Quarter for Biolife Solutions (NASDAQ:BLFS)

Biolife Solutions (NASDAQ:BLFS) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.04 EPS
Next Year EPS Consensus Estimate: $0.05 EPS

Biolife Solutions (NASDAQ BLFS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2018($0.01)N/AView Earnings Details
5/10/2018Q1 2018$0.0070($0.01)$3.81 million$3.82 millionViewN/AView Earnings Details
3/8/2018Q4 2017($0.0350)($0.05)$3.10 million$3.13 millionViewListenView Earnings Details
11/9/2017Q3 2017($0.06)($0.03)$2.60 million$2.96 millionViewN/AView Earnings Details
8/10/2017Q2 2017($0.06)($0.06)$2.40 million$2.56 millionViewN/AView Earnings Details
5/11/2017Q1 2017($0.05)($0.07)$2.10 million$2.37 millionViewN/AView Earnings Details
3/9/2017Q4 2016($0.07)($0.04)$2.20 million$2.25 millionViewListenView Earnings Details
11/10/2016Q316($0.08)($0.08)$2.20 million$2.10 millionViewN/AView Earnings Details
8/11/2016Q216($0.09)($0.11)$2.01 million$2.00 millionViewListenView Earnings Details
5/12/2016Q1($0.08)($0.10)$2.20 million$1.85 millionViewListenView Earnings Details
2/25/2016Q415($0.11)($0.09)$1.66 million$1.82 millionViewListenView Earnings Details
11/12/2015Q315($0.10)($0.09)$1.67 million$1.60 millionViewN/AView Earnings Details
8/6/2015Q215($0.10)($0.08)$1.60 million$1.50 millionViewN/AView Earnings Details
5/7/2015Q1 2015($0.09)($0.09)$1.47 million$1.50 millionViewN/AView Earnings Details
3/12/2015Q4 2014($0.08)($0.08)$1.76 million$1.67 millionViewN/AView Earnings Details
11/6/2014Q3 2014($0.07)($0.07)$1.24 million$1.24 millionViewN/AView Earnings Details
8/7/2014Q2 2014($0.05)($0.07)$1.30 million$1.21 millionViewListenView Earnings Details
5/8/2014Q1 2014$0.01($0.10)$2.33 million$2.07 millionViewN/AView Earnings Details
2/12/2014Q4 2013($0.07)($0.10)$2.34 million$2.29 millionViewN/AView Earnings Details
4/1/2013Q4 2012($0.14)ViewN/AView Earnings Details
11/13/2012Q3 2012($0.14)($0.14)ViewN/AView Earnings Details
8/14/2012Q2 2012($0.14)($0.10)ViewN/AView Earnings Details
5/14/2012Q1 2012($0.06)ViewN/AView Earnings Details
3/26/2012Q4 2011($0.08)ViewN/AView Earnings Details
11/14/2011Q3 2011($0.10)ViewN/AView Earnings Details
8/12/2011Q2 2011($0.08)ViewN/AView Earnings Details
5/16/2011Q1 2011($0.13)ViewN/AView Earnings Details
11/10/2008Q3 2008($0.14)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Biolife Solutions (NASDAQ:BLFS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Biolife Solutions (NASDAQ BLFS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 38.50%
Institutional Ownership Percentage: 11.90%
Insider Trading History for Biolife Solutions (NASDAQ:BLFS)
Institutional Ownership by Quarter for Biolife Solutions (NASDAQ:BLFS)

Biolife Solutions (NASDAQ BLFS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/15/2018Michael RiceCEOSell12,540$8.65$108,471.00152,057View SEC Filing  
4/17/2018Michael RiceCEOSell12,540$7.18$90,037.20146,157View SEC Filing  
4/9/2018Thomas GirschweilerDirectorSell1,025,000$5.26$5,391,500.00View SEC Filing  
3/15/2018Michael RiceCEOSell12,540$5.27$66,085.80View SEC Filing  
2/15/2018Michael RiceCEOSell12,540$5.26$65,960.40152,057View SEC Filing  
1/16/2018Michael RiceCEOSell12,540$5.57$69,847.80152,057View SEC Filing  
8/8/2014Raymond W CohenChairmanBuy1,250$2.48$3,100.00View SEC Filing  
5/20/2014Raymond W CohenChairmanBuy4,000$2.39$9,560.00View SEC Filing  
5/14/2014Aby J MathewCTOBuy8,600$2.33$20,038.00View SEC Filing  
5/14/2014Michael RiceCEOBuy8,000$2.56$20,480.00View SEC Filing  
5/13/2014Michael RiceCEOBuy12,767$2.26$28,853.42View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Biolife Solutions (NASDAQ BLFS) News Headlines

Source:
DateHeadline
Biolife Solutions (BLFS) and Viewray (VRAY) Head-To-Head AnalysisBiolife Solutions (BLFS) and Viewray (VRAY) Head-To-Head Analysis
www.americanbankingnews.com - May 19 at 11:25 AM
BioLife Solutions (BLFS) Shares March Higher, Can It Continue?BioLife Solutions (BLFS) Shares March Higher, Can It Continue?
www.zacks.com - May 17 at 9:25 AM
BioLife Solutions Announces Partial Redemption of Series A Preferred StockBioLife Solutions Announces Partial Redemption of Series A Preferred Stock
finance.yahoo.com - May 17 at 9:25 AM
Biolife Solutions (BLFS) CEO Sells $108,471.00 in StockBiolife Solutions (BLFS) CEO Sells $108,471.00 in Stock
www.americanbankingnews.com - May 16 at 10:28 PM
Head-To-Head Review: Biolife Solutions (BLFS) versus FC Global Realty (FCRE)Head-To-Head Review: Biolife Solutions (BLFS) versus FC Global Realty (FCRE)
www.americanbankingnews.com - May 16 at 7:18 PM
BioLife Solutions Makes Investment in SAVSU Technologies to Support Growth and Capture Additional Regenerative Medicine Cold Chain OpportunitiesBioLife Solutions Makes Investment in SAVSU Technologies to Support Growth and Capture Additional Regenerative Medicine Cold Chain Opportunities
finance.yahoo.com - May 16 at 9:26 AM
 Brokerages Set $9.67 Target Price for Biolife Solutions (BLFS) Brokerages Set $9.67 Target Price for Biolife Solutions (BLFS)
www.americanbankingnews.com - May 13 at 7:20 PM
 Brokerages Anticipate Biolife Solutions (BLFS) Will Post Quarterly Sales of $3.45 Million Brokerages Anticipate Biolife Solutions (BLFS) Will Post Quarterly Sales of $3.45 Million
www.americanbankingnews.com - May 12 at 3:00 AM
Biolife Solutions (BLFS) Given a $12.00 Price Target by Maxim Group AnalystsBiolife Solutions (BLFS) Given a $12.00 Price Target by Maxim Group Analysts
www.americanbankingnews.com - May 11 at 8:05 PM
Edited Transcript of BLFS earnings conference call or presentation 10-May-18 8:30pm GMTEdited Transcript of BLFS earnings conference call or presentation 10-May-18 8:30pm GMT
finance.yahoo.com - May 11 at 4:46 PM
Biolife Solutions (BLFS) Releases Quarterly  Earnings Results, Misses Estimates By $0.02 EPSBiolife Solutions (BLFS) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS
www.americanbankingnews.com - May 11 at 1:53 PM
BioLife Solutions (BLFS) CEO Mike Rice on Q1 2018 Results - Earnings Call TranscriptBioLife Solutions' (BLFS) CEO Mike Rice on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 10:01 AM
BioLife Solutions EPS and revenue in-lineBioLife Solutions EPS and revenue in-line
seekingalpha.com - May 10 at 4:52 PM
BioLife Solutions Announces First Quarter 2018 Financial ResultsBioLife Solutions Announces First Quarter 2018 Financial Results
finance.yahoo.com - May 10 at 4:51 PM
-$0.03 Earnings Per Share Expected for Biolife Solutions (BLFS) This Quarter-$0.03 Earnings Per Share Expected for Biolife Solutions (BLFS) This Quarter
www.americanbankingnews.com - May 10 at 1:12 PM
Biolife Solutions (BLFS) Rating Increased to Strong-Buy at ValuEngineBiolife Solutions (BLFS) Rating Increased to Strong-Buy at ValuEngine
www.americanbankingnews.com - May 5 at 2:27 PM
BioLife Solutions to Report First Quarter 2018 Financial Results and Provide Business Update on May 10, 2018BioLife Solutions to Report First Quarter 2018 Financial Results and Provide Business Update on May 10, 2018
finance.yahoo.com - May 3 at 9:06 AM
Biolife Solutions (BLFS) Set to Announce Earnings on WednesdayBiolife Solutions (BLFS) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - May 2 at 3:14 AM
Maxim Group Reiterates $9.00 Price Target for Biolife Solutions (BLFS)Maxim Group Reiterates $9.00 Price Target for Biolife Solutions (BLFS)
www.americanbankingnews.com - April 30 at 11:08 AM
BioLife Solutions Receives $2.6 Million from Exercise of WarrantsBioLife Solutions Receives $2.6 Million from Exercise of Warrants
finance.yahoo.com - April 30 at 9:22 AM
Biolife Solutions (BLFS) Expected to Announce Quarterly Sales of $3.81 MillionBiolife Solutions (BLFS) Expected to Announce Quarterly Sales of $3.81 Million
www.americanbankingnews.com - April 25 at 4:56 AM
-$0.03 EPS Expected for Biolife Solutions (BLFS) This Quarter-$0.03 EPS Expected for Biolife Solutions (BLFS) This Quarter
www.americanbankingnews.com - April 23 at 3:18 AM
 Biolife Solutions (BLFS) Given $8.83 Consensus Target Price by Brokerages Biolife Solutions (BLFS) Given $8.83 Consensus Target Price by Brokerages
www.americanbankingnews.com - April 20 at 9:22 PM
Michael Rice Sells 12,540 Shares of Biolife Solutions (BLFS) StockMichael Rice Sells 12,540 Shares of Biolife Solutions (BLFS) Stock
www.americanbankingnews.com - April 18 at 7:46 PM
Insider Selling: Biolife Solutions (BLFS) Director Sells 1,025,000 Shares of StockInsider Selling: Biolife Solutions (BLFS) Director Sells 1,025,000 Shares of Stock
www.americanbankingnews.com - April 10 at 10:17 PM
Casdin Capital to Become Shareholder in BioLife SolutionsCasdin Capital to Become Shareholder in BioLife Solutions
finance.yahoo.com - April 9 at 9:27 AM
$3.81 Million in Sales Expected for Biolife Solutions (BLFS) This Quarter$3.81 Million in Sales Expected for Biolife Solutions (BLFS) This Quarter
www.americanbankingnews.com - April 8 at 5:02 AM
Biolife Solutions (BLFS) Rating Increased to Buy at ValuEngineBiolife Solutions (BLFS) Rating Increased to Buy at ValuEngine
www.americanbankingnews.com - April 3 at 6:58 PM
Zacks: Analysts Set $8.50 Price Target for Biolife Solutions (BLFS)Zacks: Analysts Set $8.50 Price Target for Biolife Solutions (BLFS)
www.americanbankingnews.com - April 3 at 9:19 AM
BioLife Solutions (BLFS) Announces Prelim. Q1 Revenue of $3.8 MillionBioLife Solutions (BLFS) Announces Prelim. Q1 Revenue of $3.8 Million
www.streetinsider.com - April 2 at 4:41 PM
Maxim Group Analysts Give Biolife Solutions (BLFS) a $9.00 Price TargetMaxim Group Analysts Give Biolife Solutions (BLFS) a $9.00 Price Target
www.americanbankingnews.com - April 2 at 3:16 PM
BioLife solutions announces preliminary Q1 results; shares ahead 7% premarketBioLife solutions announces preliminary Q1 results; shares ahead 7% premarket
seekingalpha.com - April 2 at 9:43 AM
BioLife Solutions Announces Preliminary First Quarter 2018 Revenue of $3.8 Million, up 61% Year-over-Year and 22% SequentiallyBioLife Solutions Announces Preliminary First Quarter 2018 Revenue of $3.8 Million, up 61% Year-over-Year and 22% Sequentially
finance.yahoo.com - April 2 at 9:43 AM
BioLife Solutions and SAVSU Technologies to be Awarded Second Patent for Next Generation Cold Chain Technologies Designed for Cell and Gene TherapiesBioLife Solutions and SAVSU Technologies to be Awarded Second Patent for Next Generation Cold Chain Technologies Designed for Cell and Gene Therapies
finance.yahoo.com - March 26 at 9:37 AM
Biolife Solutions (BLFS) Expected to Post Quarterly Sales of $3.14 MillionBiolife Solutions (BLFS) Expected to Post Quarterly Sales of $3.14 Million
www.americanbankingnews.com - March 22 at 8:08 AM
Biolife Solutions (BLFS) Expected to Post Earnings of -$0.03 Per ShareBiolife Solutions (BLFS) Expected to Post Earnings of -$0.03 Per Share
www.americanbankingnews.com - March 20 at 5:14 AM
Maxim Group Analysts Give Biolife Solutions (BLFS) a $8.00 Price TargetMaxim Group Analysts Give Biolife Solutions (BLFS) a $8.00 Price Target
www.americanbankingnews.com - March 19 at 5:02 PM
BioLife Solutions Inc (BLFS) CEO Sells $66,085.80 in StockBioLife Solutions Inc (BLFS) CEO Sells $66,085.80 in Stock
www.americanbankingnews.com - March 16 at 8:32 PM
BioLife Solutions CryoStor® Cell Freeze Media Highlighted in Mayo Clinic/MD Anderson Journal Article on Preservation of Patient-Derived Xenografts for Cancer ResearchBioLife Solutions CryoStor® Cell Freeze Media Highlighted in Mayo Clinic/MD Anderson Journal Article on Preservation of Patient-Derived Xenografts for Cancer Research
finance.yahoo.com - March 13 at 9:31 AM
BioLife Solutions (BLFS) Coverage Initiated at Northland SecuritiesBioLife Solutions (BLFS) Coverage Initiated at Northland Securities
www.americanbankingnews.com - March 12 at 1:44 PM
Maxim Group Reiterates $8.00 Price Target for BioLife Solutions (BLFS)Maxim Group Reiterates $8.00 Price Target for BioLife Solutions (BLFS)
www.americanbankingnews.com - March 10 at 5:10 PM
Brokerages Expect BioLife Solutions Inc (BLFS) to Announce ($0.03) Earnings Per ShareBrokerages Expect BioLife Solutions Inc (BLFS) to Announce ($0.03) Earnings Per Share
www.americanbankingnews.com - March 10 at 3:22 PM
BioLife Solutions (BLFS) Announces  Earnings ResultsBioLife Solutions (BLFS) Announces Earnings Results
www.americanbankingnews.com - March 9 at 10:35 AM
BioLife Solutions Announces Fourth Quarter and Full Year 2017 Financial ResultsBioLife Solutions Announces Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 8 at 5:36 PM
BioLife Solutions, Inc. to Host Earnings CallBioLife Solutions, Inc. to Host Earnings Call
finance.yahoo.com - March 8 at 5:36 PM
When Will BioLife Solutions Inc (NASDAQ:BLFS) Breakeven?When Will BioLife Solutions Inc (NASDAQ:BLFS) Breakeven?
finance.yahoo.com - March 8 at 5:36 PM
BioLife Solutions to Report Fourth Quarter and Full Year 2017 Financial Results and Provide Business Update on March 8, 2018BioLife Solutions to Report Fourth Quarter and Full Year 2017 Financial Results and Provide Business Update on March 8, 2018
finance.yahoo.com - March 1 at 5:00 PM
Michael Rice Sells 12,540 Shares of BioLife Solutions Inc (BLFS) StockMichael Rice Sells 12,540 Shares of BioLife Solutions Inc (BLFS) Stock
www.americanbankingnews.com - February 16 at 10:20 PM
BioLife Solutions Executes OEM Agreement with MilliporeSigmaBioLife Solutions Executes OEM Agreement with MilliporeSigma
finance.yahoo.com - February 13 at 9:24 AM
BioLife Solutions Announces SAVSU Alliance with World CourierBioLife Solutions Announces SAVSU Alliance with World Courier
finance.yahoo.com - January 23 at 3:56 PM

SEC Filings

Biolife Solutions (NASDAQ:BLFS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Biolife Solutions (NASDAQ:BLFS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Biolife Solutions (NASDAQ BLFS) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.